Delivery Order SPE2DB24D3013-SPE2DB26FFFXA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Lumigan 0.01% Eye Drops (5mL) with a ceiling value of $1,173.24. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on September 26, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,374.22 to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (2.5 mL) on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed-price, non-set-aside contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $8,896.43 to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5ml) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitive award utilizes firm fixed price pricing with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,470.15 on August 6, 2025, for the supply of Lumigan 0.01% eye drops in 5mL quantities. This non-set-aside contract employs firm fixed price terms with an ultimate completion date of August 7, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,768.84 to AmerisourceBergen Drug Corp for the supply of Lumigan 0.01% eye drops (5ml) on July 15, 2025, with an ultimate completion date of July 16, 2025. This firm fixed-price contract represents a non-set-aside competitive award and is classified as a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lumigan 0.01% eye drops in 5mL quantities under a firm fixed price contract. The award, issued on August 19, 2025, carries a ceiling value of $2,108.68 with an ultimate completion date of August 20, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- The Defense Logistics Agency awarded a $2,121.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5ml), with an ultimate completion date of August 18, 2025. This contract represents a non-set-aside competitive award and is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of LUMIGAN 0.01% eye drops. The $4,409.48 contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor on this order, which is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to provide a comprehensive range of pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,616.96 to Amerisourcebergen Drug Corporation for the supply of 2.5ml Lumigan 0.01% eye drops. Amerisourcebergen Drug Corporation will perform as the prime contractor, with corporate oversight provided by its parent company, Amerisourcebergen Corporation. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance spanning August 1...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at two hundred twenty-three thousand one hundred ten dollars to Amerisourcebergen Drug Corporation for the supply of Lumigan 0.01% eye drops. Under this contract, Amerisourcebergen will deliver 2.5mL bottles of the ophthalmic solution to a location in Conshohocken, Pennsylvania by September 15, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB26FFFXADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Lumigan 0.01% eye drops in 2.5ml units, with a contract ceiling value of $1,419.54 and an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreements with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen functions as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, supplying medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 10/27/25 |